Hyperparathyroidism, Secondary
-
Subject Areas on Research
- Active vitamin D and survival.
- Beyond minerals and parathyroid hormone: role of active vitamin D in end-stage renal disease.
- Complementary nature of radiotracer parathyroid imaging and intraoperative parathyroid hormone assays in the surgical management of primary hyperparathyroid disease: case report and review.
- Disordered FGF23 and mineral metabolism in children with CKD.
- Diuretics, calciuria and secondary hyperparathyroidism in the Chronic Renal Insufficiency Cohort.
- Effect of Etelcalcetide vs Cinacalcet on Serum Parathyroid Hormone in Patients Receiving Hemodialysis With Secondary Hyperparathyroidism: A Randomized Clinical Trial.
- Effect of Etelcalcetide vs Placebo on Serum Parathyroid Hormone in Patients Receiving Hemodialysis With Secondary Hyperparathyroidism: Two Randomized Clinical Trials.
- Effect of cinacalcet on cardiovascular disease in patients undergoing dialysis.
- Effects of calcitriol and non-calcemic vitamin D analogs on secondary hyperparathyroidism.
- Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease.
- Fibroblast growth factor-23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in chronic kidney disease.
- Hypercalcemia in patients with advanced chronic renal failure not yet requiring dialysis.
- Images in clinical medicine. Pseudoclubbing.
- Impact of activated vitamin D and race on survival among hemodialysis patients.
- In experimental chronic kidney disease or cancer, parathyroid hormone is a novel mediator of cachexia.
- Intraoperative parathyroid hormone monitoring during parathyroidectomy for secondary hyperparathyroidism.
- Leontiasis ossea in secondary hyperparathyroidism.
- Oral calcitriol and calcium: efficient therapy for uremic hyperparathyroidism.
- Osteomalacia after parathyroidectomy in patients with uremia.
- Parathyroid hormone independently predicts fracture, vascular events, and death in patients with stage 3 and 4 chronic kidney disease.
- Paricalcitol versus cinacalcet plus low-dose vitamin D therapy for the treatment of secondary hyperparathyroidism in patients receiving haemodialysis: results of the IMPACT SHPT study.
- Postprandial mineral metabolism and secondary hyperparathyroidism in early CKD.
- Predictors of short-term changes in serum intact parathyroid hormone levels in hemodialysis patients: role of phosphorus, calcium, and gender.
- Prevalence and severity of disordered mineral metabolism in Blacks with chronic kidney disease.
- Prospective trial of pulse oral versus intravenous calcitriol treatment of hyperparathyroidism in ESRD.
- Risk of secondary hyperparathyroidism after laparoscopic gastric bypass surgery in obese women.
- Second Chances to Improve ESRD Outcomes With a Second-Generation Calcimimetic.
- Subtotal vs. total parathyroidectomy with autotransplantation for patients with renal hyperparathyroidism have similar outcomes.
- Surgical management of secondary hyperparathyroidism.
- The American Association of Endocrine Surgeons Guidelines for the Definitive Surgical Management of Secondary and Tertiary Renal Hyperparathyroidism.
- Thymic carcinoid tumors with hyperparathyroidism.
- Vanishing leg ulcers.
- Vitamin D Receptor Agonists for Patients Undergoing Hemodialysis.
- When there will never be a randomized controlled trial.